suramin has been researched along with mifepristone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ding, Y; Gao, ZG; Jacobson, KA; Suffredini, AF | 1 |
2 other study(ies) available for suramin and mifepristone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells.
Topics: Adenosine Triphosphate; Calcium Signaling; Cell Adhesion Molecules; Cell Line; Chemokine CCL2; Cytokines; Dexamethasone; DNA-Binding Proteins; Dose-Response Relationship, Drug; Endothelial Cells; Gene Expression; Gene Expression Profiling; Humans; Inflammation Mediators; Interleukin-6; Intracellular Signaling Peptides and Proteins; Kinetics; Lipopolysaccharides; Mifepristone; Nuclear Proteins; Nucleotides; p38 Mitogen-Activated Protein Kinases; Purinergic P2 Receptor Antagonists; Receptors, Glucocorticoid; Receptors, Purinergic P2Y2; RNA, Small Interfering; Signal Transduction; Suramin; Tumor Necrosis Factor alpha-Induced Protein 3; Type C Phospholipases; Up-Regulation | 2010 |